Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
164.28B
Market cap164.28B
Price-Earnings ratio
19.19
Price-Earnings ratio19.19
Dividend yield
6.87%
Dividend yield6.87%
Average volume
45.24M
Average volume45.24M
High today
$27.19
High today$27.19
Low today
$26.47
Low today$26.47
Open price
$26.59
Open price$26.59
Volume
32.57M
Volume32.57M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $26.96, with a market capitalization of 164.28B. The stock trades at a price-to-earnings (P/E) ratio of 19.19 and offers a dividend yield of 6.87%.

On 2026-08-10, Pfizer(PFE) stock traded between a low of $26.47 and a high of $27.19. Shares are currently priced at $26.96, which is +1.9% above the low and -0.8% below the high.

The Pfizer(PFE)'s current trading volume is 32.57M, compared to an average daily volume of 45.24M.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

PFE News

The Motley Fool 50m
Pfizer's Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?

Dividend cuts don't typically happen without warning. Investors can see a business that's in trouble. Perhaps it's in the midst of a turnaround, it's restructur...

Pfizer's Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?
Simply Wall St 1d
Pfizer Stock Leads 3 AI Healthcare Picks Built For Smarter Care

Global energy prices now respond quickly to geopolitical events, which keeps pressure on healthcare systems to do more with constrained budgets and staff. That...

Pfizer Stock Leads 3 AI Healthcare Picks Built For Smarter Care
TipRanks 2d
Pfizer Advances COVID Pipeline As Analysts Eye Upside - TipRanks

...

Pfizer Advances COVID Pipeline As Analysts Eye Upside - TipRanks

Analyst ratings

60%

of 30 ratings
Buy
33.3%
Hold
60%
Sell
6.7%

More PFE News

Nasdaq 3d
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound

Key Points Pfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound. There are several other reasons to consider the...

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
TipRanks 3d
Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study

Pfizer Inc (PFE), Biontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium t...

Simply Wall St 4d
Why Pfizer Is Up 5.2% After Raising 2026 Guidance Despite a Q2 Net Loss

In the second quarter of 2026, Pfizer reported revenue of US$15,034 million, up from US$14,653 million a year earlier, but swung from net income of US$2,910 mil...

Why Pfizer Is Up 5.2% After Raising 2026 Guidance Despite a Q2 Net Loss
TipRanks 4d
Pfizer Completes Key Early Study on PF-07328948, Sharpening Its Long-Term Pipeline Story

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

TipRanks 4d
Pfizer and BioNTech Lock In Next-Gen Pediatric COVID Booster Edge

Pfizer Inc (PFE), Biontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium t...

Simply Wall St 5d
Pfizer Stock Trades At A Premium Despite Its 27% Five Year Fall

Pfizer stock has rebounded over the past year after a weak few years, yet the broader valuation checks and current market multiples still suggest the shares are...

Pfizer Stock Trades At A Premium Despite Its 27% Five Year Fall
TipRanks 5d
Pfizer price target raised to $27 from $26 at BofA

BofA raised the firm’s price target on Pfizer (PFE) to $27 from $26 and keeps a Neutral rating on the shares. Despite a “solid” Q2, the firm expects Pfizer to c...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.